- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Accumetrics launches bedside diagnostic tool
Cardiovascular diagnostic device developer Accumetrics has begun shipping its Ultegra point-of-care diagnostic system, designed to measure platelet function in patients undergoing coronary interventional procedures. The portable device can assess
Cardiovascular diagnostic device developer Accumetrics has begun shipping its Ultegra point-of-care diagnostic system, designed to measure platelet function in patients undergoing coronary interventional procedures. The portable device can assess platelet function at the bedside from a whole blood sample in less than two minutes, according to the San Diego-based company, and enables cardiologists to measure the effects of certain inhibitors in the cardiac cath lab. The Ultegra system is intended to serve as a platform for other point-of-care diagnostic applications Accumetrics intends to bring to market, according to Terry Johnson, president and CEO.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
